Asthma Surveillance and Education in Preschool Settings
This study has been completed.
Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:
NCT00201071
First received: September 12, 2005
Last updated: August 10, 2016
Last verified: April 2007
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to test the effectiveness of a bilingual intervention in improving asthma care for low-income inner-city children enrolled in subsidized preschool childcare programs.
| Condition |
|---|
|
Asthma |
| Study Type: | Observational |
| Study Design: | Observational Model: Family-Based Time Perspective: Prospective |
| Official Title: | Asthma Surveillance and Education in Preschool Settings |
Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):
| Enrollment: | 208 |
| Study Start Date: | September 2004 |
| Study Completion Date: | January 2011 |
| Primary Completion Date: | February 2010 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
| South Bronx, Harlem, Lower East Side |
Detailed Description:
BACKGROUND:
Proposed is a non-randomized, controlled, prospective trial to test the efficacy of a bilingual intervention to improve asthma care for low-income inner-city children enrolled in subsidized preschool childcare programs. Because of high rates of asthma prevalence, subsidized preschool childcare programs offer ideal settings to test innovative strategies to improve asthma care within communities at highest risk of morbidity.
DESIGN NARRATIVE:
The study will comprise three arms. Arm 1 is surveillance, in which children with asthma are identified. In Arm 2, children with asthma are identified and given written Asthma Action Plans (monitoring). Arm 3 consists of surveillance, monitoring, and education.
Eligibility| Ages Eligible for Study: | 2 Years to 4 Years (Child) |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
We formed collaborative agreements with subsidized day care providers in three New York City communities with high asthma prevalence. These three communities - Harlem, the South Bronx and the Lower East Side - are economically disadvantaged communities of color. Participants were parents or guardians of children with asthma enrolled in subsidized day care center. 95% of participants were female, 64% were Hispanic, 25% were Black, 1% were White and 10% were Other. 70% were born in the continental USA, 70% spoke English as their primary language. 30% had earned less than a HS degree, 32% had received a HS diploma or a GED, 37% had attended som college, and 1% had completed college. 33% of participants had family incomes of less than $1,000 per month, 35% had incomes of $1,000 to $1,999 and 32% had incomes over $2,000.
Criteria
Inclusion Criteria:
- Enrolled in specific subsidized preschools in New York City
- 2.8 to 4 years old
- Persistent asthma as defined by symptom reports
- Use of quick-relief agents or controller medications
Exclusion Criteria:
- History of intubation
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00201071
Please refer to this study by its ClinicalTrials.gov identifier: NCT00201071
Locations
| United States, New York | |
| The New York Academy of Medicine, CUES | |
| New York, New York, United States, 10029 | |
Sponsors and Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
| Principal Investigator: | Sebastian Bonner, PhD | The New York Academy of Medicine, CUES |
More Information
Additional Information:
| Responsible Party: | National Heart, Lung, and Blood Institute (NHLBI) |
| ClinicalTrials.gov Identifier: | NCT00201071 History of Changes |
| Other Study ID Numbers: | 1298 R01HL076592 |
| Study First Received: | September 12, 2005 |
| Last Updated: | August 10, 2016 |
| Health Authority: | United States: Federal Government |
Additional relevant MeSH terms:
|
Asthma Bronchial Diseases Respiratory Tract Diseases Lung Diseases, Obstructive Lung Diseases |
Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Immune System Diseases |
ClinicalTrials.gov processed this record on September 27, 2016